Description

▪ Introduction

Exemestane 25 mg by Novotex Pharma is a pharmaceutical-grade compound containing Exemestane, an irreversible steroidal aromatase inhibitor studied for its role in hormonal regulation research. Known for its ability to suppress estrogen synthesis, Exemestane is widely used in laboratory investigations focusing on estrogen-dependent mechanisms and enzymatic inhibition of aromatase. Manufactured under stringent quality control, this formulation ensures high purity and consistency for laboratory and analytical applications.

▪ Product Details (Bulleted)

• Active Ingredient: Exemestane

• Dosage Strength: 25 mg per tablet

• Form: Oral tablets

• Brand: Novotex Pharma

• Package Size: 60 Tablets

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Exemestane is rapidly absorbed via oral administration, with peak plasma concentrations occurring within 2 hours. The compound has a half-life of approximately 24 hours, facilitating once-daily research protocols. It is metabolized hepatically and excreted through urine and feces. Exemestane selectively inhibits the aromatase enzyme, reducing estrogen biosynthesis without significantly affecting other steroid pathways.

▪ Usage Recommendations

• Typical Experimental Dosage: 25 mg once daily

• Administration Route: Oral ingestion with water, ideally postprandial for optimal absorption

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is strictly intended for laboratory research and analytical use. Not approved for human consumption or medical application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with any health conditions. All handling must follow institutional protocols and local regulations.